M33 Long-term efficacy of nintedanib is maintained in patients with idiopathic pulmonary fibrosis (ipf) irrespective of dose: subgroup analysis of inpulsis-on
Conferences
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- December 2017
has subject area
- 1103 Clinical Sciences (FoR)
- Respiratory System (Science Metrix)
published in
- Thorax Journal